Similarly, a previous study revealed that cell viability and colony formation were reduced after E2F2 expression knockdown in non-small cell lung cancer (NSCLC) cells, indicating that E2F2 acts as an activator in tumor progression of the NSCLC [48]. Here, E2F2 is linked to non-small cell lung carcinoma.